Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
. The successful candidate will work with a diverse range of techniques, including biochemical assays, long-read sequencing and super-resolution microscopy. The project’s focus will be shaped to align with
-
, multiple transcriptomics and genomics approaches, single-cell sequencing, and histocytometry) Set up bioinformatics platforms and develop computational pipelines for the analysis of bulk and single-cell RNA
-
systems. We are also running a sequencing facility and conduct translational studies using human samples or genetically engineered model organisms. Multidisciplinary teams of cancer biologists, mouse
-
Postdoc (f/m/d) on Generative AI for de Novo Protein Design / Completed university studies (PhD) ...
/m/d) on Generative AI for de Novo Protein Design. Your tasks # Design of generative AI models (e.g., VAEs, GANs, Diffusion Models) to create novel protein sequences, fold structures, and functional
-
multi-disciplinary approaches to answer these key questions including; immunology, oncology (in vitro model-organoid systems, ex vivo tissue culture), microbiology, next generation sequencing (16S seq
-
.: CAR-T, Virotherapy, BiTEs). We aim to use small DNA molecules to cleave target sequences and thereby improve anti tumor immunity. Experience in immunology, tumor biology, molecular biology, and delivery
-
, which aims to identify novel targets for male contraception. In this research project, we will be using cutting edge sequencing datasets (e.g. single cell RNA-seq, methylome) as well as cell and tissue
-
., 2020; Hersperger et al., 2024). Our lab employs a combination of approaches such as genetic screens, single nuclei RNA-sequencing, live imaging, fate mapping approaches and reporter lines, and
-
of sequencing-driven, microbiological, and immunological approaches on gnotobiotic mouse models and patient cohorts (e.g., El Mouali et al., Cell Host Microbe, 2024; Osbelt et al., Nature Microbiology, 2024
-
to improve patient care. These efforts are enabled by our department's world-leading collection of brain tumour samples which are complemented by DNA methylation, DNA and RNA sequencing as well as clinical